Every recall we track for Amerigen Pharmaceuticals Inc. — 4 in all, from 2018–2019 — plus the complaints and injury reports the public filed about them.
Recalls on record by year — 4 drug.
Amerigen Pharmaceuticals recalls 5mg Temozolomide capsules (5-count and 14-count bottles) due to failed dissolution specifications. This is a prescription-only medication.
Amerigen Pharmaceuticals recalls 14-count Temozolomide capsules (180mg) due to failed dissolution specifications. Patients should contact their doctor for guidance.
Amerigen Pharmaceuticals recalls 20mg Temozolomide capsules (5-count and 14-count bottles) due to failed dissolution testing. These prescription drugs may not release medication properly.
4 recalls from Amerigen Pharmaceuticals Inc. are on record with U.S. safety agencies, from 2018–2019.
Amerigen Pharmaceuticals Inc. recalls Temozolomide Capsules, 5 mg, packaged in a) 5-count bottle (NDC 43975-252-05) b) 14-count bottle (NDC 43975-252-14), Rx, dated Feb 19, 2019. Every Amerigen Pharmaceuticals Inc. recall is listed on this page, newest first.
The most common reasons on record: Failed Dissolution Specifications (2).
Match the NDC and lot number on your bottle or box to the recall. Don’t stop a prescription on your own — ask your pharmacist or doctor for a replacement first. Report side effects to FDA MedWatch.
Sign up for free email alerts on GovInfoNow — we check official CPSC, FDA, USDA and NHTSA data every day and email you only when a recall matches what you follow.
